Jason Cassorla

Stock Analyst at Citigroup

(2.14)
# 2,738
Out of 4,681 analysts
41
Total ratings
52.94%
Success rate
5.12%
Average return

Stocks Rated by Jason Cassorla

PACS Group
Sep 11, 2024
Reinstates: Buy
Price Target: $45
Current: $15.90
Upside: +183.02%
Surgery Partners
Aug 7, 2024
Maintains: Buy
Price Target: $38$36
Current: $23.81
Upside: +51.20%
Tenet Healthcare
Jul 25, 2024
Maintains: Buy
Price Target: $139$171
Current: $142.03
Upside: +20.40%
Universal Health Services
Feb 29, 2024
Maintains: Buy
Price Target: $170$193
Current: $201.06
Upside: -4.01%
HCA Healthcare
Oct 25, 2023
Maintains: Buy
Price Target: $324$279
Current: $327.63
Upside: -14.84%
Clover Health Investments
Aug 11, 2023
Maintains: Neutral
Price Target: $1$1.5
Current: $3.43
Upside: -56.27%
Community Health Systems
May 3, 2023
Maintains: Buy
Price Target: $9$7
Current: $3.42
Upside: +104.68%
Enhabit
Feb 17, 2023
Maintains: Neutral
Price Target: $16$18
Current: $7.86
Upside: +129.01%
InnovAge Holding
Nov 16, 2022
Maintains: Neutral
Price Target: $5$8
Current: $4.90
Upside: +63.27%
ATI Physical Therapy
Nov 8, 2022
Maintains: Neutral
Price Target: $70$60
Current: $1.68
Upside: +3,471.43%